-
1دورية أكاديمية
المؤلفون: Nosrati, Adi1, Tsai, Katy K1, Goldinger, Simone M2, Tumeh, Paul3, Grimes, Barbara4, Loo, Kimberly1, Algazi, Alain P1, Nguyen-Kim, Thi Dan Linh5, Levesque, Mitchell2, Dummer, Reinhard2, Hamid, Omid6, Daud, Adil1
المصدر: British Journal of Cancer. 4/25/2017, Vol. 116 Issue 9, p1141-1147. 7p. 1 Diagram, 4 Charts, 1 Graph.
مصطلحات موضوعية: *MELANOMA treatment, *AGE distribution, *ANTIGENS, *COMPARATIVE studies, *GENES, *IMMUNOTHERAPY, *LACTATE dehydrogenase, *RESEARCH methodology, *MEDICAL cooperation, *MELANOMA, *MONOCLONAL antibodies, *PROGNOSIS, *RESEARCH, *TUMOR classification, *EVALUATION research
-
2دورية أكاديمية
المؤلفون: Algazi, Alain P.1 alain.algazi@ucsf.edu, Tsai, Katy K.1, Shoushtari, Alexander N.2, Munhoz, Rodrigo R.2, Eroglu, Zeynep3, Piulats, Josep M.4, Ott, Patrick A.5, Johnson, Douglas B.6, Hwang, Jimmy1, Daud, Adil I.1, Sosman, Jeffrey A.6, Carvajal, Richard D.7, Chmielowski, Bartosz8, Postow, Michael A.2, Weber, Jeffrey S.9, Sullivan, Ryan J.10
المصدر: Cancer (0008543X). Nov2016, Vol. 122 Issue 21, p3344-3353. 11p.
مصطلحات موضوعية: *UVEA, *MELANOMA treatment, *PROGRAMMED cell death 1 receptors, *CANCER immunotherapy, *HEALTH outcome assessment, *PEMBROLIZUMAB, *TUMOR treatment, *TUMORS, *THERAPEUTICS, *ANTINEOPLASTIC agents, *ANTIGENS, *CLINICAL trials, *COMPARATIVE studies, *LONGITUDINAL method, *RESEARCH methodology, *MEDICAL cooperation, *MELANOMA, *MONOCLONAL antibodies, *MUCOUS membranes, *PROGNOSIS, *RESEARCH, *SURVIVAL, *TUMOR classification, *EVALUATION research, *RETROSPECTIVE studies
-
3دورية أكاديمية
المؤلفون: Shoushtari, Alexander N., Munhoz, Rodrigo R., Kuk, Deborah, Ott, Patrick A., Johnson, Douglas B., Tsai, Katy K., Rapisuwon, Suthee, Eroglu, Zeynep, Sullivan, Ryan J., Luke, Jason J., Gangadhar, Tara C., Salama, April K. S., Clark, Varina, Burias, Clare, Puzanov, Igor, Atkins, Michael B., Algazi, Alain P., Ribas, Antoni, Wolchok, Jedd D., Postow, Michael A.
المصدر: Cancer (0008543X); Nov2016, Vol. 122 Issue 21, p3354-3362, 10p
مصطلحات موضوعية: MELANOMA treatment, PROGRAMMED cell death 1 receptors, APOPTOSIS, PEMBROLIZUMAB, CANCER immunotherapy, THERAPEUTICS, ANTINEOPLASTIC agents, ANTIGENS, BRAIN tumors, COMPARATIVE studies, LIVER tumors, LONGITUDINAL method, RESEARCH methodology, MEDICAL cooperation, MELANOMA, MONOCLONAL antibodies, MUCOUS membranes, PROGNOSIS, RESEARCH, RESEARCH funding, SKIN tumors, SURVIVAL, TUMOR classification, EVALUATION research, RETROSPECTIVE studies